G Nine Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.78 M
About G Nine Formulations
G Nine Formulations Private Limited (GNFPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 August 2002 and has a history of 22 years and six months. Its registered office is in Jalandhar, Punjab, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.78 M.
Anjana Arora, Manmohan Tandon, Suresh Tandon, and One other member serve as directors at the Company.
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232PB2002PTC025336
- Company No.
025336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Aug 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does G Nine Formulations Private Limited offer?
G Nine Formulations Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Cosmetics, Hair & Beauty Products, Hair Oil, Psoriasis Ointment, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Digestive System Drugs & Medicines, Laxatives, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at G Nine Formulations?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjana Arora  | Director | 30-Nov-2018 | Current |
| Manmohan Tandon | Director | 12-Aug-2002 | Current |
| Suresh Tandon | Director | 12-Aug-2002 | Current |
| Jitender Arora | Director | 12-Aug-2002 | Current |
Financial Performance of G Nine Formulations.
G Nine Formulations Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of G Nine Formulations?
In 2017, G Nine Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Northern India Consultants Private LimitedManmohan Tandon is a mutual person
Charges (Loans)
₹7.78 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.78 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2017 | Canara Bank | ₹4.28 M | Open |
| 10 Feb 2003 | Canara Bank | ₹3.50 M | Open |
How Many Employees Work at G Nine Formulations?
Unlock and access historical data on people associated with G Nine Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G Nine Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G Nine Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
